Differential Associations of Inflammatory Biomarkers and Clinical Risk Factors with Acute Coronary Syndrome versus Ischemic Stroke: A Comparative Hospital-Based Study in Northwest Iran

Imagine your body as a bustling city with two main highways: one delivering fuel to the heart (the coronary arteries) and another transporting oxygen to the brain (the cerebral arteries). Sometimes, traffic jams or roadblocks happen on these highways, causing a heart attack (Acute Coronary Syndrome) or a stroke (Ischemic Stroke). While both disasters stem from the same root cause—clogged roads due to plaque buildup—they often look different when they strike. Scientists have long known that the "weather" inside the body, specifically the level of inflammation (think of it as the city's emergency response system or smoke rising from a fire), plays a role in these events. But here's the mystery: does the smoke look the same whether the fire is in the heart or the brain? And do men and women react differently to this smoke? Most studies have looked at these highways separately, or focused on Western cities, leaving a gap in our understanding of how these events compare in other parts of the world, like the Middle East.

This study, conducted by researchers in Northwest Iran, decided to play detective by comparing two groups of patients who arrived at the hospital with these exact emergencies. They gathered 285 people: 150 with heart attacks and 135 with strokes. Instead of just guessing, they looked at the "smoke detectors" in the blood—specifically a marker called hs-CRP (high-sensitivity C-reactive protein) and the total count of white blood cells (WBC), which are the body's security guards. They also checked the drivers' profiles: age, gender, blood pressure, smoking habits, and family history. The goal was to see if the "smoke" and the "driver profiles" could tell them which highway was blocked just by looking at the blood test results when the patient first walked in.

The investigation revealed some fascinating differences between the two groups. The stroke patients were, on average, older (about 66 years old) and significantly more likely to be women (54.8%) compared to the heart attack group (who were about 61 years old and mostly men). When it came to the "smoke," the stroke patients had a much higher level of hs-CRP in their blood (averaging 26.84 mg/L) compared to the heart attack patients (only 3.37 mg/L). It was as if the stroke patients' bodies were screaming louder with inflammation. On the flip side, the heart attack patients were much more likely to be smokers (54.0% vs. 29.6%) and had higher levels of "bad" cholesterol (LDL) in their blood.

The researchers built a mathematical model to see if they could predict which condition a patient had based on these clues. The results were quite clear: higher levels of hs-CRP and higher blood pressure were strong signs pointing toward a stroke, while higher LDL cholesterol and being male were signs pointing toward a heart attack. Interestingly, the study found that the relationship between these blood markers and the type of emergency did not change based on whether the patient was a man or a woman. Even though scientists had wondered if men and women might react differently to inflammation, this study found no evidence to support that idea; the "smoke" behaved the same way regardless of gender.

One of the most powerful findings was that combining the blood markers with simple clinical facts (like age, gender, and blood pressure) created a very accurate "detector." This combined model could distinguish between a stroke and a heart attack with about 90.8% accuracy (an AUC of 0.908), which was significantly better than using just the blood markers alone (which were about 80.9% accurate). This suggests that while inflammation is a key player, you need the whole picture—including blood pressure and history—to get the best read on what's happening.

However, the researchers are careful to note that this is a "hypothesis-generating" study, meaning it raises important questions for future research rather than providing a final, unchangeable rule. Because they recruited heart patients from one hospital and stroke patients from another, they can't be 100% sure that the differences they found aren't influenced by how those specific hospitals operate. They also noted that the data was collected at the moment of the emergency, so these markers show what was happening during the event, not necessarily what caused it years ago. Despite these limitations, the study offers a rare, direct look at how these two major vascular emergencies differ in a Middle Eastern population, suggesting that inflammation, blood pressure, and cholesterol tell different stories depending on which highway is blocked.